Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Jubilant Life Sciences

Sector: Healthcare | Industry: Drugs & Pharma
R 481.15 -0.30  | -0.06% -30.51% 13.75 7,657.44
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 481.15 -0.30 -0.06% 483.00 481.45 199,530 476.45 - 485.35
BSE Oct 15, 2019 480.75 0.60 0.13% 484.80 480.15 19,976 468.00 - 485.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue9,214.039,110.827,517.845,861.435,749.13 5,826.255,803.36
Other Income35.9735.7440.0324.8613.37 42.4519.06
Total Income9,250.009,146.567,557.875,886.295,762.51 5,868.705,822.42
Total Expenditure7,478.027,371.815,999.454,516.144,502.19 5,124.714,782.37
Operating Profit1,771.981,774.751,558.411,370.151,260.32 743.991,040.05
Interest265.16219.81284.28341.11371.35 367.61337.11
PBDT1,506.821,554.941,274.131,029.04888.97 376.38702.95
Depreciation385.59370.90415.05291.40346.74 287.95281.17
PBT & Exceptional Items1,121.231,184.04859.08737.64542.22 88.43421.78
Exceptional Items-234.76-280.23--- -48.10-214.49
Profit before Tax886.47903.81859.08737.64542.22 40.32207.28
Provision for Tax324.85326.80224.66163.02155.40 80.4869.64
Profit after Tax561.62577.01634.42574.63386.82 -40.16137.64
Minority Interest-4.68-2.558.391.035.01 -17.60-28.60
Share of Associate0.00---- --
Consolidated Profit556.94574.46642.81575.65391.83 -57.76109.04
 
LiabilitiesR Cr
Share Capital15.9315.9315.5815.5815.54 15.9315.45
Total Reserves4,792.994,792.944,070.793,419.982,950.72 2,437.592,611.07
Shareholder's Funds4,808.924,808.924,086.533,436.042,966.26 2,453.522,626.51
Minority Interest0.100.10-51.52-47.39-38.13 -157.94
Long Term Borrowings4,242.894,242.893,047.813,505.033,013.21 3,691.291,716.88
Other Non Current Liabilities326.87177.32369.66321.02333.92 344.86468.07
Current Liabilities2,089.732,089.732,004.691,684.042,464.44 2,129.163,894.42
Total Debt*-4,840.433,468.894,045.294,493.26 4,793.124,395.28
Total Liabilities11,468.5111,318.969,457.178,898.758,739.70 8,618.838,863.81
 
AssetsR Cr
Net Block4,099.265,648.385,400.555,106.735,104.42 4,911.335,098.78
Non Current Investments115.11115.11123.52102.7185.43 39.5033.99
Other Non-Current Assets2,669.34970.68743.34741.19674.52 953.46803.01
Current Investments----- --
Cash and Bank1,370.411,370.41248.79459.63344.58 394.34479.53
Other Current Assets3,214.393,214.392,940.962,488.492,530.74 2,320.202,448.50
Net Current Assets2,495.072,495.071,185.061,264.08410.88 585.38-966.39
Miscellaneous Exp. Not Written Off----- --
Total Assets11,468.5111,318.969,457.178,898.758,739.70 8,618.838,863.81
 
Cash FlowR Cr
From Operations-1,121.511,303.201,268.491,098.89 783.26772.27
From Investing Activities--1,011.84-617.70-450.40-312.53 -343.33-174.42
From Finance Activities-657.43-901.14-685.87-842.75 -502.69-414.41
Net Inflow/Outflow-767.10-215.63132.23-56.39 -62.76183.44
 
Key Ratios
Adjusted EPS (Rs)34.9736.0741.2736.9625.22 -3.637.06
Adjusted Book Value (Rs)313.52301.93262.33220.61190.90 154.04170.07
Dividend per Share (Rs)-4.503.003.003.00 3.003.00
Cash Flow per Share (Rs)-70.4283.6681.4570.72 49.1850.00
Debt to Equity0.881.010.851.181.51 1.951.67
Current Ratio2.192.191.591.751.17 1.270.75
ROCE (%)-13.0615.2114.4412.42 5.727.92
RONW (%)12.6312.9716.8717.9514.27 -1.585.39
Operating Margin (%)19.2319.4820.7323.3821.92 12.7717.92
Net Margin (%)6.076.318.399.766.71 -0.682.36
Revenue Growth (%)14.6021.1928.261.95-1.32 0.3912.34
Net Profit Growth (%)-18.73-9.0510.4148.551,063.20 -129.18-27.09
EPS Growth (%)-20.51-12.6011.6446.58795.35 -151.37-26.37
Book Value Growth (%)-17.6818.9415.8220.90 -6.596.07
 
Market Cues
Close Price (Rs)481.15664.80839.45799.80416.85 152.90158.95
High Price (Rs)898.85898.851,039.00832.75454.90 222.00187.80
Low Price (Rs)391.05586.35600.00285.00137.00 115.6066.10
Market Cap (Rs Cr)7,657.4410,578.7113,081.5612,434.266,469.25 2,428.222,454.05
Price / Earnings13.7518.4220.3521.6016.51 0.0022.51
Price / Book Value1.532.203.203.622.18 0.990.93
Dividend Yield (%)0.940.680.360.380.72 1.971.89
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
2.71
Piotroski F-Score
5
Modified C-Score
1
5-Years Price to Earnings
13.75
5-Years Price to Book
1.53
Earnings Yield
EBIT / Enterprise value
10.35%
PEG
Price / Earnings to growth ratio
0.58
Related Stocks
  Current Price   Chng %
Abbott India R10,917.90 -0.74%
Alkem Laboratories R1,915.10 -1.38%
Biocon R260.30 +2.74%
Cadila Healthcare R234.45 +0.75%
Cipla R446.55 +1.28%
Glaxosmithkline Pharma R1,433.15 +2.66%
Lupin R721.15 +0.66%
Pfizer R3,193.15 +0.75%
Piramal Enterprises R1,375.85 -0.05%
Torrent Pharmaceuticals R1,699.85 +0.11%
As on Oct 15, 15:59